SWOG S1400B

Primary Category:

Treatment Protocols

Disease Category:

Lung, Lung - Non-Small Cell, Lung - Non-Small Cell Metastatic, Molecular Profiling

Status:

Closed

A Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)

(See required screening study SWOG S1400)

S1400B is closed to accrual effective December 12, 2016, as the study did not meet the criterion for the interim futility analysis.

NCT#02154490

Leave a Reply